Skip to main content

Table 3 Adherence to AMI evidence-based treatment in the follow-up of 3449 patients

From: Is depression a real risk factor for acute myocardial infarction mortality? A retrospective cohort study

EBT class

Antidepressant use

Total (n. 3449)

Yes (n. 281)

No (n. 3168)

n

(%)

n

(%)

n

(%)

Aspirin/Clopidogrel

242

(86.1)

2879

(90.9)

3121

(90.5)

Beta-blockers

185

(65.8)

2308

(72.9)

2493

(72.3)

Statins

176

(62.6)

2293

(72.4)

2469

(71.6)

ACEIs/ARBs

184

(65.5)

2344

(74.0)

2528

(73.3)

Combination EBT

121

(43.1)

1630

(51.5)

1751

(50.8)

  1. EBT evidence-based treatment, ACEIs angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers